Patents by Inventor Catherine To

Catherine To has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of EphA3 as a Marker of the Presence of a Solid Tumor
    Publication number: 20170335001
    Abstract: The invention provides methods and compositions for detecting non-hematopoietic, non-tumor EphA3-expressing cells in cancer patients and for monitoring the prognosis of patients using EphA3.
    Type: Application
    Filed: July 8, 2016
    Publication date: November 23, 2017
    Inventors: Martin Lackmann, Andrew Mark Scott, Catherine To, Christopher R. Bebbington, Geoffrey T. Yarranton, Mark Baer, Varghese Palath
  • EphA3 antibodies for the treatment of solid tumors
    Patent number: 8637016
    Abstract: The invention provides methods and compositions comprising anti-EphA3 antibodies for the treatment of solid tumors.
    Type: Grant
    Filed: March 10, 2008
    Date of Patent: January 28, 2014
    Assignees: KaloBios Pharmaceuticals, Inc., Monash University, Ludwig Institute for Cancer Research Limited
    Inventors: Martin Lackmann, Andrew Mark Scott, Christopher R. Bebbington, Geoffrey T. Yarranton, Carmelina Murone, Catherine To
  • DETECTION OF EPHA3 AS A MARKER OF THE PRESENCE OF A SOLID TUMOR
    Publication number: 20110318304
    Abstract: The invention provides methods and compositions for detecting non-hematopoietic, non-tumor EphA3-expressing cells in cancer patients and for monitoring the prognosis of patients using EphA3.
    Type: Application
    Filed: June 20, 2011
    Publication date: December 29, 2011
    Inventors: Martin Lackmann, Andrew Mark Scott, Catherine To, Christopher R. Bebbington, Geoffrey T. Yarranton, Mark Baer, Varghese Palath
  • EphA3 Antibodies for the Treatment of Solid Tumors
    Publication number: 20080286272
    Abstract: The invention provides methods and compositions comprising anti-EphA3 antibodies for the treatment of solid tumors.
    Type: Application
    Filed: March 10, 2008
    Publication date: November 20, 2008
    Applicants: KaloBios Pharmaceuticals, Inc., Ludwig Institute for Cancer Research, Monash University
    Inventors: Martin Lackmann, Andrew Mark Scott, Christopher R. Bebbington, Geoffrey T. Yarranton, Carmelina Murone, Catherine To